Matches in Wikidata for { <http://www.wikidata.org/entity/Q91500250> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- Q91500250 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q91500250 description "scientific article published on 17 September 2018" @default.
- Q91500250 description "wetenschappelijk artikel" @default.
- Q91500250 description "наукова стаття, опублікована у вересні 2018" @default.
- Q91500250 name "Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)" @default.
- Q91500250 name "Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)" @default.
- Q91500250 type Item @default.
- Q91500250 label "Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)" @default.
- Q91500250 label "Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)" @default.
- Q91500250 prefLabel "Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)" @default.
- Q91500250 prefLabel "Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)" @default.
- Q91500250 P1433 Q91500250-AA52E9A6-C681-45CB-947D-9B0842EAEBA1 @default.
- Q91500250 P1476 Q91500250-064E857A-380E-4210-A681-BB72AF2C1762 @default.
- Q91500250 P2093 Q91500250-1C326DE3-6ABB-4B53-A20F-D331CF2195E0 @default.
- Q91500250 P2093 Q91500250-1FA47699-F85E-4EA1-A9D5-A30937F23022 @default.
- Q91500250 P2093 Q91500250-20B6B7F3-C505-4E17-9129-FB2FA84474D3 @default.
- Q91500250 P2093 Q91500250-279CC2C0-01E7-43DB-91A8-EDF135839A22 @default.
- Q91500250 P2093 Q91500250-29250741-E5F5-4529-B654-62783C0EEEBC @default.
- Q91500250 P2093 Q91500250-2F960BAE-8678-4D32-88A0-3C1BA28222F9 @default.
- Q91500250 P2093 Q91500250-30F14FF8-8D81-47AD-A58A-D910167E5FED @default.
- Q91500250 P2093 Q91500250-3BF06BBE-4D21-4E4F-81F9-4ED1827128C4 @default.
- Q91500250 P2093 Q91500250-3DC5C29C-1D17-4F95-BB47-AB952B928C2F @default.
- Q91500250 P2093 Q91500250-68023AD9-FD8D-429F-97CE-462744902AF5 @default.
- Q91500250 P2093 Q91500250-68942853-8B19-47FB-8606-283C36A2C68A @default.
- Q91500250 P2093 Q91500250-6B7FBBE0-78D0-4DED-A977-F782F75EFDF0 @default.
- Q91500250 P2093 Q91500250-837649FB-7DFB-408D-8E38-67508639564E @default.
- Q91500250 P2093 Q91500250-886914E0-7E9D-4326-8B51-09E154EE129B @default.
- Q91500250 P2093 Q91500250-9B9E4611-B143-4B74-8458-2EC731F6A206 @default.
- Q91500250 P2093 Q91500250-A947B7D2-4047-4FFB-808A-739A4BDFDC82 @default.
- Q91500250 P2093 Q91500250-D9EB594C-D805-4D33-9B2A-5D124CE1A08E @default.
- Q91500250 P2093 Q91500250-E01B5135-2655-4F0E-9E4E-BC2A4E247D99 @default.
- Q91500250 P2093 Q91500250-E81E3A34-9915-439C-BC2E-A74477F49FDF @default.
- Q91500250 P2093 Q91500250-EB451B81-A502-41CA-9E5E-BECF5545B10F @default.
- Q91500250 P2093 Q91500250-FEE27CAD-FDE2-43D9-BB8E-C7FF01A705D2 @default.
- Q91500250 P304 Q91500250-0290B53A-E8E0-404A-BE46-95049977E22F @default.
- Q91500250 P31 Q91500250-67A3652B-D889-4777-A3A5-5CA08A891F03 @default.
- Q91500250 P356 Q91500250-A75C1D55-994A-470A-A23E-291B5F00B05D @default.
- Q91500250 P433 Q91500250-34E76BF5-A4A3-4D0F-9E52-02656D83329D @default.
- Q91500250 P478 Q91500250-CCECD703-21A9-4684-8C9C-CB39D716FDF8 @default.
- Q91500250 P50 Q91500250-A76ED42C-C0D2-4704-97C3-CA08885C23F0 @default.
- Q91500250 P577 Q91500250-B1BDB0A3-82D2-45B8-AF18-D2EC8084783F @default.
- Q91500250 P698 Q91500250-68CE2759-0CEB-441D-AE05-4B6C498C060C @default.
- Q91500250 P921 Q91500250-9788FBFA-A086-47CC-B26D-25F3CE41703C @default.
- Q91500250 P356 S00280-018-3682-9 @default.
- Q91500250 P698 30225601 @default.
- Q91500250 P1433 Q326137 @default.
- Q91500250 P1476 "Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)" @default.
- Q91500250 P2093 "Ana Reig" @default.
- Q91500250 P2093 "Angels Ginés" @default.
- Q91500250 P2093 "Antonio Ferrández" @default.
- Q91500250 P2093 "Berta Laquente" @default.
- Q91500250 P2093 "Carles Conill" @default.
- Q91500250 P2093 "Carlos Valls" @default.
- Q91500250 P2093 "Ignacio Povés" @default.
- Q91500250 P2093 "Javier Rodriguez" @default.
- Q91500250 P2093 "Joan Fabregat" @default.
- Q91500250 P2093 "Joan Maurel" @default.
- Q91500250 P2093 "Josep Antoni Bombí" @default.
- Q91500250 P2093 "Juan Ramón Ayuso" @default.
- Q91500250 P2093 "Laura Visa" @default.
- Q91500250 P2093 "Laureano Fernández-Cruz" @default.
- Q91500250 P2093 "Luis Sabater" @default.
- Q91500250 P2093 "Lydia Gaba" @default.
- Q91500250 P2093 "Marta Martín-Richard" @default.
- Q91500250 P2093 "María Cambray" @default.
- Q91500250 P2093 "Roberto Díaz-Beveridge" @default.
- Q91500250 P2093 "Susana Roselló" @default.
- Q91500250 P2093 "Xabier García-Albéniz" @default.
- Q91500250 P304 "935-943" @default.
- Q91500250 P31 Q13442814 @default.
- Q91500250 P356 "10.1007/S00280-018-3682-9" @default.
- Q91500250 P433 "6" @default.
- Q91500250 P478 "82" @default.
- Q91500250 P50 Q57046891 @default.
- Q91500250 P577 "2018-09-17T00:00:00Z" @default.
- Q91500250 P698 "30225601" @default.
- Q91500250 P921 Q212961 @default.